SCHEMBL12450833

SCHEMBL12450833

[C-]#[N+]COCC(F)(F)[C@@](N)(CC)c1ccccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12273629 0.75 KCNN4 (0.36) —
SCHEMBL12450813 0.71 CYP3A4 (0.30) —
SCHEMBL12450817 0.68 PTPN7 (0.30) —
SCHEMBL27901491 0.64 KCNN4 (0.44) —
SCHEMBL21058252 0.64 KCNN4 (0.38) —
SCHEMBL27321412 0.63 ACHE (0.37) —
SCHEMBL12478801 0.63 TACR1 (0.30) —
SCHEMBL12478800 0.63 TACR1 (0.30) —
SCHEMBL14165902 0.61 KCNN4 (0.37) —
SCHEMBL15524860 0.61 KCNN4 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748418-B2 1,4-oxazepines as BACE1 and/or BACE2 inhibitors HOFFMANN-LA ROCHE INC. (US) 2014-06-10 — — US disclosed
US-20120238548-A1 1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-09-20 — — US disclosed
Send feedback